Literature DB >> 20462650

Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice.

Noriyuki Obara1, Koji Fukushima, Yoshiyuki Ueno, Yuta Wakui, Osamu Kimura, Keiichi Tamai, Eiji Kakazu, Jun Inoue, Yasuteru Kondo, Norihiko Ogawa, Kenta Sato, Tsuyoshi Tsuduki, Kazuyuki Ishida, Tooru Shimosegawa.   

Abstract

BACKGROUND & AIMS: Excessive trans-fatty acids (TFA) consumption has been thought to be a risk factor mainly for coronary artery diseases while less attention has been paid to liver disease. We aimed to clarify the impact of TFA-rich oil consumption on the hepatic pathophysiology compared to natural oil.
METHODS: Mice were fed either a low-fat (LF) or high-fat (HF) diet made of either natural oil as control (LF-C or HF-C) or partially hydrogenated oil, TFA-rich oil (LF-T or HF-T) for 24 weeks. We evaluated the liver and body weight, serological features, liver lipid content and composition, liver histology and hepatic lipid metabolism-related gene expression profile. In addition, primary cultures of mice Kupffer cells (KCs) were evaluated for cytokine secretion and phagocytotic ability after incubation in cis- or trans-fatty acid-containing medium.
RESULTS: The HF-T-fed mice showed significant increases of the liver and body weights, plasma alanine-aminotransferase, free fatty acid and hepatic triglyceride content compared to the HF-C group, whereas the LF-T group did not differ from the LF-C group. HF-T-fed mice developed severe steatosis, along with increased lipogenic gene expression and hepatic TFA accumulation. KCs showed increased tumor necrosis factor secretion and attenuated phagocytotic ability in the TFA-containing medium compared to its cis-isomer.
CONCLUSIONS: Excessive consumption of the TFA-rich oil up-regulated the lipogenic gene expression along with marked hepatic lipid accumulation. TFA might be pathogenic through causing severe steatosis and modulating the function of KCs. The quantity and composition of dietary lipids could be responsible for the pathogenesis of non-alcoholic steatohepatitis. Copyright 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462650     DOI: 10.1016/j.jhep.2010.02.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

Review 1.  Lipotoxicity in the liver.

Authors:  Veronika Zámbó; Laura Simon-Szabó; Péter Szelényi; Eva Kereszturi; Gábor Bánhegyi; Miklós Csala
Journal:  World J Hepatol       Date:  2013-10-27

Review 2.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 3.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

Review 4.  The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.

Authors:  Marina Nati; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.349

5.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

6.  Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats.

Authors:  Sugeedha Jeyapal; Uday Kumar Putcha; Venkata Surekha Mullapudi; Sudip Ghosh; Anil Sakamuri; Suryam Reddy Kona; Sai Santosh Vadakattu; Chandana Madakasira; Ahamed Ibrahim
Journal:  Eur J Nutr       Date:  2017-07-04       Impact factor: 5.614

7.  Circulating and dietary trans fatty acids and incident type 2 diabetes in older adults: the Cardiovascular Health Study.

Authors:  Qianyi Wang; Fumiaki Imamura; Wenjie Ma; Molin Wang; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Mary L Biggs; Joseph A Delaney; Kenneth J Mukamal; Luc Djousse; David S Siscovick; Dariush Mozaffarian
Journal:  Diabetes Care       Date:  2015-03-17       Impact factor: 19.112

8.  The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats.

Authors:  Madiha Dhibi; Faten Brahmi; Amira Mnari; Zohra Houas; Issam Chargui; Linda Bchir; Noureddine Gazzah; Mohammed A Alsaif; Mohamed Hammami
Journal:  Nutr Metab (Lond)       Date:  2011-09-23       Impact factor: 4.169

Review 9.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

10.  Lipotoxicity: effects of dietary saturated and transfatty acids.

Authors:  Débora Estadella; Claudia M da Penha Oller do Nascimento; Lila M Oyama; Eliane B Ribeiro; Ana R Dâmaso; Aline de Piano
Journal:  Mediators Inflamm       Date:  2013-01-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.